Ticker brief
PRME
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
7
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-20 → 2026-06-30 · now +0.35 (−1 bearish … +1 bullish)
Who spoke7
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BioStocks | C | -0.39 | 2 | +0.48 |
| @CaesarCapitalz | C | +3.91 | 1 | +0.65 |
| @theflynews | C | · | 1 | +0.50 |
| @BiopharmIQ | B | · | 1 | +0.45 |
| @InvestmentGuru_ | C | +0.03 | 1 | +0.25 |
| @TLAMB91 | C | -0.61 | 1 | +0.20 |
| @TradesWithTom | C | +0.90 | 1 | +0.35 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-30 | @TradesWithTom | +0.35 | Says PRME daily breakout is holding above resistance. | · | tweet ↗ |
| 2026-06-29 | @TLAMB91 | +0.20 | Recaps prior ARKG breakout call and TWST leader gain of 60% in a month. | · | tweet ↗ |
| 2026-06-29 | @InvestmentGuru_ | +0.25 | Three biotech companies on author's radar. | · | tweet ↗ |
| 2026-06-29 | @BioStocks | +0.40 | PRME upgraded to Buy at HCW with $8 price target. | · | tweet ↗ |
| 2026-06-22 | @BiopharmIQ | +0.45 | Biotech stock moves list with percentage changes and associated clinical/regulatory headlines. | · | tweet ↗ |
| 2026-06-22 | @theflynews | +0.50 | Prime Medicine received RMAT designation for PM359. | · | tweet ↗ |
| 2026-06-22 | @BioStocks | +0.55 | PRME receives FDA RMAT designation for PM359. | · | tweet ↗ |
| 2026-06-20 | @CaesarCapitalz | +0.65 | Presents favorite AI/biotech stocks and explains innovation and partnerships. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.